NTM Info & Research is a national nonprofit dedicated to supporting patients with the progressive lung disease. The nonprofit ...

How can we address the challenges associated with the highly heterogeneous nature of bronchiectasis? This review aimed to discuss the concepts of phenotype and endotype and the recent advancements in ...

Findings reveal that a structured home rehabilitation program boosts lung function and quality of life in bronchiectasis ...

BRONCHIECTASIS is protean in its expressions as it is sometimes obscure in its origin. The clinical picture varies in individual patients, but common to the severer cases is a history of harassing, ...

Bronchiectasis may affect a few parts of the lung or be limited to a single lobe, depending on the etiology of the disease. Other symptoms may include shortness of breath, chest pain, and joint pain.

Being overweight or obese may lower all-cause mortality risks in non–cystic fibrosis (CF) bronchiectasis patients, while ...

Researchers also observed differences in 10-year mortality probability among those with suspected bronchiectasis in the PRISm group (0.07; 95% CI, –0.003 to 0.15) and in the obstructive ...

We introduced domiciliary intravenous (IV) antibiotic therapy in patients with bronchiectasis to promote patient-centred domiciliary treatment instead of hospital inpatient treatment. To assess ...

In 1941 Riggins 1 wrote: "The morbidity and mortality of untreated and medically treated bronchiectasis is such that the physician who routinely advises young adults with operable bronchiectasis ...

Patients with bronchiectasis from different European countries have strikingly different variations in microbiome composition and resistome.